Target intelligence / Profile preview

Peripheral nociceptive nerve fiber

Molecular classification
Ion channel, G protein-coupled receptor, Receptor, Other
01

Overview

Peripheral nociceptive nerve fibers, commonly known as nociceptors, are specialized high-threshold sensory neurons responsible for detecting and transmitting signals of potential or actual tissue damage to the central nervous system (StatPearls, 2023). These fibers are primarily categorized into two types: thinly myelinated A-delta fibers, which mediate rapid, sharp pain, and unmyelinated C-fibers, which convey slower, dull, or aching pain (NIH, 2001). They express a variety of specialized proteins, including voltage-gated sodium channels (Nav1.7, Nav1.8) and transient receptor potential (TRP) channels, which convert mechanical, thermal, or chemical stimuli into electrical impulses (PubMed, 2013). In pathological states, these fibers can become sensitized through inflammatory mediators, leading to chronic pain conditions such as neuropathy or hyperalgesia (Nature Reviews Neuroscience, 2014). Pharmacological interventions often target these fibers by blocking ion conductance or desensitizing receptors to interrupt the pain signaling pathway (StatPearls, 2023). For instance, local anesthetics like lidocaine inhibit sodium channels to prevent signal propagation, while topical capsaicin desensitizes TRPV1 receptors (DrugBank, 2024).

Other names
NociceptorPrimary afferent neuronA-delta fiberC-fiberPain-sensing neuronSmall diameter sensory fiberNociceptive afferent
02

Mechanism of action

Drugs targeting these fibers act by inhibiting voltage-gated sodium channels (e.g., Nav1.7, Nav1.8) to block action potential propagation, modulating voltage-gated calcium channels (alpha2-delta subunit) to reduce excitatory neurotransmitter release, or activating and subsequently desensitizing TRPV1 channels to exhaust the fiber's signaling capacity (StatPearls, 2023; PubMed, 2013).

03

Biological functions

NociceptionSignal transductionPain transmissionPeripheral sensitizationSensory perception
04

Disease associations

Chronic painNeuropathic painInflammatory painHyperalgesiaAllodyniaSmall fiber neuropathy
05

Safety considerations

Loss of protective sensationParesthesiaNumbnessLocal anesthetic systemic toxicity (LAST)NeurotoxicityRisk of secondary injury due to analgesia
06

Interacting drugs

Lidocaine

8 more in the full profile.

07

Biomarkers

Intraepidermal nerve fiber density (IENFD)Quantitative sensory testing (QST)Nerve growth factor (NGF) levels

Beyond the preview

Go deeper on Peripheral nociceptive nerve fiber.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peripheral nociceptive nerve fiber.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call